InvestorsHub Logo

manibiotech

12/13/19 8:50 PM

#255679 RE: Umibe5690 #255678

There will be muted response even now with being on OTC and a year away from approval I think unless they announce some kind of partnership

oka888

12/14/19 5:19 AM

#255694 RE: Umibe5690 #255678

try april 2023

sentiment_stocks

12/14/19 10:22 AM

#255706 RE: Umibe5690 #255678

I think the ASM will be sometime in mid January, not February. You may have meant to write that; however your post reads differently. I certainly hope we have topline by then (mid January), but acknowledge it’s entirely possible it won’t be until sometime in February as well. The process has got to work it’s way through the regulators and that is what is MOST paramount here, despite what anyone else thinks (I’m sure you, umibe agrees, I’m just writing this for those who think differently). And each of the regulators likely work differently and have different approaches to the process. One may prefer to receive the entire SAP submitted as one package, while another might prefer to have been receiving it in sections, or yet some other manner. I don’t think the submittal process is the same for each RA. Regardless, the company will have to abide by the RA’s timelines and what will be with the share price, will be. If there are strong hands, with more money to invest and prop it up as we near unblinding and top line, then the price is unlikely to fall. If there aren’t strong hands here, and everyone wants to dump now, for tax purposes or whatever, possibly weeks to a month or two from top line, so be it.

Whatever happens to the share price will NOT speed up or slow down the RA process.

hyperopia

12/14/19 1:01 PM

#255723 RE: Umibe5690 #255678

If the ASM comes and goes without TLD, the PPS will tank to new lows in the teens if not single digits.


Hmmmm where have I heard that before? Oh yeah, it was right here on ihub, in a very long series of posts from . . . Umibe5690.

colmar   Friday, 05/10/19 06:45:53 AM
Re: None

Post # 226673 of 255712 
Predictions on share price if we don't get topline by ASCO?


Umibe5690   Friday, 05/10/19 07:04:16 AM
Re: colmar post# 226673

Post # 226677 of 255712 
It will rapidly collapse to $0.15 and go to single digits if nothing is announced by September. Between now and ASCO, it is white knuckles as we turbulently approach landing. GLTA.


Umibe5690   Sunday, 05/12/19 06:37:07 AM
Re: Etienne1 post# 226989

Post # 226996 of 255713 
No top line announcement by ASCO and nothing new of any substance is revealed wrt DC VAX L by then, the share price gets taken to the woodshed. One sentence, how's that?


Umibe5690   Friday, 05/24/19 12:36:34 AM
Re: Poor Man - post# 228826

Post # 228830 of 255713 
No top line until SNO is a prescription for single digit share price. They don't need to wait until then. Announcement of top line should not depend upon conference venues. At this point, good news just climbs us out of an avoidable hole that management has dug for itself.

And more detailed analysis should not be delayed until then either, unless top line results are so impressive and undeniable that further analysis fleshes out the already irrefutable results.
JMHO.